Matrix metalloproteinases (MMPs), in particular, MMP-2 and MMP-9, have been investigated for their role as potential blood biomarkers for OSA, as they are related to the pathophysiological mechanisms of OSA, such as chronic intermittent hypoxia and systemic inflammation [3–5]. The gene discussed is MMP9; the disease is obstructive sleep apnea syndrome.